Babio's novel Coronavirus Antigen products won the "white List" of many countries

Recently, The Novel Coronavirus (2019-NCOV) antigen test (colloidal gold method) independently developed by Babco has won the "whitelist" of Belgium and Portugal, adding a new tool to the global fight against COVID-19.  

Since 2020, Babio Bio has entered the overseas market, and a number of rapid detection products are rapidly realizing the global layout.  In 2021, The Company passed the certification of a number of European and American authorities, for example, Novel Coronavirus (SARS-COV-2) Rapid antigen detection reagent (colloidal gold method) obtained the "White List" of Germany BfArM, Italy Ministry of Health, Austria, etc.  At the same time, Babio biological virus sampling tube on the EUA white list of the United States FDA, the enterprise through ISO13485 certification, sterile swab issued by Intertek CE certificate (announcement agency no. : 0413) and FDA.  

The award of the important qualification for The novel coronavirus antigen detection product of Bioba once again shows the recognition of the overseas market for bioba's products, and will further help Bioba to serve the global COVID-19 prevention and control.